Jump to content

Alfaxalone: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
No edit summary
No edit summary
Line 2: Line 2:
| IUPAC_name = 3-hydroxypregnane-11,20-dione
| IUPAC_name = 3-hydroxypregnane-11,20-dione
| image = Alphaxolone-2D-skeletal.png
| image = Alphaxolone-2D-skeletal.png
| CAS_number =
| CAS_number = 23930-19-0
| ATC_prefix = N01
| ATC_prefix = N01
| ATC_suffix = AX05
| ATC_suffix = AX05

Revision as of 08:02, 11 August 2009

Alfaxalone
Clinical data
ATC code
Pharmacokinetic data
BioavailabilityThe alfaxalone molecule is solubilised in the Alfaxan formulation using 2α- hydroxypropyl ß cyclodextrin. Cyclodextrins are complex polysaccharides derived from starch that supply a hydrophobic centre for lipophilic drugs like alfaxalone.
Identifiers
  • 3-hydroxypregnane-11,20-dione
CAS Number
PubChem CID
CompTox Dashboard (EPA)
ECHA InfoCard100.164.405 Edit this at Wikidata
Chemical and physical data
FormulaC21H32O3
Molar mass332.477 g/mol g·mol−1

Alfaxalone (INN, also known as alphaxalone or alphaxolone) is a neurosteroid general anaesthetic. It is one of the constituents of althesin. It is used in veterinary practice under the tradename Alfaxan. It is licensed for use in both dogs and cats. Unlike some of its predecessors Alfaxalone is not associated with histamine release and anaphylaxis. The primary mechanism for the anaesthetic action of alfaxalone is modulation of neuronal cell membrane chloride ion transport, induced by binding of alfaxalone to GABAA cell surface receptors. It has also been shown that Alfaxalone binds to a different region of this receptor than the benzodiazipines (1). Alfaxalone is metabolised rapidly in the liver. Alfaxalone has a very short plasma elimination half-life in dogs and cats

See Also

References

  • Mihic SJ, Whiting PJ, Klein RL, et al. A single amino acid of the human gamma-aminobutyric acid type A receptor gamma 2 subunit determines benzodiazepine efficacy. J Biol Chem 1994;269:32768-32773.